Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Musa, Mayer"'
Autor:
Genie Han, Musa Mayer, Joseph Canner, Kristina Lindsley, Reva Datar, Jimmy Le, Annette Bar-Cohen, Janice Bowie, Kay Dickersin
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Evidence-based healthcare (EBHC) principles are essential knowledge for patient and consumer (“consumer”) engagement as research and research implementation stakeholders. The aim of this study was to assess whether participati
Externí odkaz:
https://doaj.org/article/8b2d094ddf8841709314aaec191daba6
Supplemental materials contain details of the methods, validation and results. Supplemental Figure 1. Age-adjusted SEER incidence-based (IB) mortality rates for cases diagnosed in the SEER-9 areas between 1975-2012 by stage at diagnosis. Supplemental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3ad4a1522b472f213c9d7e7e9ca9d9
https://doi.org/10.1158/1055-9965.22438539.v1
https://doi.org/10.1158/1055-9965.22438539.v1
Autor:
Denise A. Yardley, Marianne Ulcickas Yood, Mona Shing, Melissa G. Brammer, Lisa I. Wang, Iulia Cristina Tudor, Debu Tripathy, Elizabeth Tan-Chiu, Peter A. Kaufman, Hope S. Rugo, Musa Mayer, Adam M. Brufsky
Purpose: registHER is a prospective, observational study of 1,023 newly diagnosed HER2-positive metastatic breast cancer (MBC) patients.Experimental Design: Baseline characteristics of patients with and without central nervous system (CNS) metastases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4e6b2407eb34ab03f653a8dc6472aa
https://doi.org/10.1158/1078-0432.c.6518999.v1
https://doi.org/10.1158/1078-0432.c.6518999.v1
Background: Distant metastatic breast cancer (MBC), including metastases found at diagnosis (de novo) and those occurring later (recurrence), represents the most severe form of the disease, when resource utilization is most intensive. Yet, the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b83d16348c77b4bc8ad30a85d0f8ab
https://doi.org/10.1158/1055-9965.c.6516411.v1
https://doi.org/10.1158/1055-9965.c.6516411.v1
Publikováno v:
Cancer
Background The extent of breast cancer outcome disparity can be measured by comparing Surveillance, Epidemiology, and End Results (SEER) breast cancer‐specific survival (BCSS) by region and with institutional cohort (IC) rates. Methods Patients who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba0b8cc22d836e5afe8f4835173fa63
https://doi.org/10.1002/cncr.32531
https://doi.org/10.1002/cncr.32531
Autor:
Musa Mayer
Publikováno v:
PLoS Medicine, Vol 2, Iss 11, p e358 (2005)
Externí odkaz:
https://doaj.org/article/a7abe6654808477fbe1172b8b62ae892
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:809-815
Background: Distant metastatic breast cancer (MBC), including metastases found at diagnosis (de novo) and those occurring later (recurrence), represents the most severe form of the disease, when resource utilization is most intensive. Yet, the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc798efaa45554916fbc53ca02c0e59c
https://doi.org/10.1158/1055-9965.epi-16-0889
https://doi.org/10.1158/1055-9965.epi-16-0889
Autor:
Debu Tripathy, D. A. Yardley, Musa Mayer, Ginny Mason, Mohammad Jahanzeb, Laura Chu, Adam Brufsky, Melody A. Cobleigh, Bongin Yoo, Mary S. Beattie, Peter A. Kaufman, HS Rugo, S Hurvitz, Sandra M. Swain, Vincent Antao, Joyce A. O'Shaughnessy
Publikováno v:
Cancer Research. 77:P5-08
Introduction In 2010, the cutoff for HR positivity in breast cancer was established as ≥1% of cells staining HR+, previously having varied from 1% to 10%. The impact of this change on treatment patterns and outcomes is poorly understood. SystHERs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f88c06146ba1ffe0f860b866dcc1967
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-27
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-27
Autor:
Musa Mayer, Laura Chu, HS Rugo, Debu Tripathy, D. A. Yardley, Melody A. Cobleigh, Mohammad Jahanzeb, Ginny Mason, Bongin Yoo, Adam Brufsky, Mary S. Beattie, Peter A. Kaufman, Joyce A. O'Shaughnessy, Vincent Antao, S Hurvitz, Sandra M. Swain
Publikováno v:
Cancer Research. 77:P5-08
Introduction HR+ metastatic breast cancer (MBC) generally has a more indolent course than HR– MBC. Less is known about differences in BL characteristics and disease outcomes by HR status in HER2+ MBC in the modern tx setting where patients (pts) ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e32bdf42a92ee48a808a3d9e9930593
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-08
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-08
Publikováno v:
Breast Cancer Management. 5:151-160
Aim: The Make Your Dialogue Count survey aimed to explore communication gaps between patients/caregivers and oncologists, and the needs of patients/caregivers at diagnosis and most recent treatment change. Methods: Three distinct sets of parallel que
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd08058767d85a497dd13f92c5357abb
https://doi.org/10.2217/bmt-2016-0023
https://doi.org/10.2217/bmt-2016-0023